These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 19681689

  • 1. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R, Lada O, Marcellin P.
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract] [Full Text] [Related]

  • 2. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
    Kaplan DD, Reddy KR.
    Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
    [No Abstract] [Full Text] [Related]

  • 3. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
    Koike K.
    J Gastroenterol; 2002 Sep; 37(11):988-90. PubMed ID: 12483259
    [No Abstract] [Full Text] [Related]

  • 4. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Lamivudine treatment consensus from relative experts in 2003].
    Lamivudine Clinical Practice Group.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):497-9. PubMed ID: 12939188
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment and selection criteria for chronic hepatitis B].
    Gunji T, Omata M.
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():309-12. PubMed ID: 15453336
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D, Prince AM.
    N Engl J Med; 2004 Mar 11; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract] [Full Text] [Related]

  • 12. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA.
    Methods Mol Med; 2004 Mar 11; 96():499-537. PubMed ID: 14762289
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B.
    Chan HL, Wong VW, Chim AM, Chan HY, Wong GL, Sung JJ.
    Aliment Pharmacol Ther; 2010 Dec 11; 32(11-12):1323-31. PubMed ID: 21050234
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of hepatitis B].
    Telegdy L.
    Orv Hetil; 2004 Nov 07; 145(45):2293-6. PubMed ID: 15573894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M.
    Gastroenterol Clin Biol; 2006 Oct 07; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.